(19)
(11) EP 2 970 257 A1

(12)

(43) Date of publication:
20.01.2016 Bulletin 2016/03

(21) Application number: 14709488.2

(22) Date of filing: 21.02.2014
(51) International Patent Classification (IPC): 
C07D 471/04(2006.01)
A61K 31/437(2006.01)
A61P 35/00(2006.01)
(86) International application number:
PCT/US2014/017751
(87) International publication number:
WO 2014/158528 (02.10.2014 Gazette 2014/40)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 14.03.2013 US 201361781070 P
10.02.2014 US 201414176506

(71) Applicant: AbbVie Inc.
North Chicago, IL 60064 (US)

(72) Inventors:
  • TAO, Zhi-Fu
    Vernon Hills, IL 60061 (US)
  • WANG, Xilu
    Libertyville, IL 60048 (US)
  • WENDT, Michael, D.
    Vernon Hills, IL 60061 (US)
  • SOUERS, Andrew, J.
    Libertyville, IL 60048 (US)
  • JUDD, Andrew, S.
    Grayslake, IL 60030 (US)
  • KUNZER, Aaron
    Arlington Heights, IL 60004 (US)
  • SULLIVAN, Gerard
    Lake Villa, IL 60046 (US)

(74) Representative: Modiano, Micaela Nadia et al
Modiano & Partners Thierschstrasse 11
80538 München
80538 München (DE)

   


(54) APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES